Search research articles
Contact Us
Filters
Showing results (161-170 of 179) with videos related to
Page
of 18
Sort By:
Annals of Internal Medicine
|
December 1, 1979
Complete remissions in metastatic breast cancer treated with combination drug therapy
S S Legha, A U Buzdar, T L Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1987
Evaluation of high-dose versus standard FAC chemotherapy for advanced breast cancer in protected environment units: a prospective randomized study
G N Hortobagyi, G P Bodey, A U Buzdar, et al.
Cancer Treatment Reports
|
January 1, 1980
Chemoimmunotherapy for metastatic breast cancer with 5-fluorouracil, adriamycin, cyclophosphamide, methotrexate, L-asparaginase, Corynebacterium parvum, and Pseudomonas vaccine
G N Hortobagyi, H Y Yap, C L Wiseman, et al.
In Vivo (Athens, Greece)
|
November 1, 1991
Immunological properties of melanoma tumor-infiltrating lymphocytes before and after IL-2-based biotherapies
K Itoh, C M Balch, J L Murray, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 14, 2006
Multicenter phase III randomized trial of polychemotherapy (CVD regimen) versus the same chemotherapy (CT) plus subcutaneous interleukin-2 and interferon-alpha2b in metastatic melanoma
E Bajetta, M Del Vecchio, P Nova, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1995
Phase II trial of docetaxel in patients with advanced cutaneous malignant melanoma previously untreated with chemotherapy
A Y Bedikian, G R Weiss, S S Legha, et al.
Melanoma Research
|
June 4, 1998
DNA damage in peripheral blood mononuclear cells correlates with response to biochemotherapy in melanoma
A C Buzaid, F Ali-Osman, N Akande, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy
|
October 1, 1991
Study of tumor-infiltrating lymphocytes for adoptive therapy of renal cell carcinoma (RCC) and metastatic melanoma: sequential proliferation of cytotoxic natural killer and noncytotoxic T cells in RCC
K Hayakawa, M A Salmeron, D R Parkinson, et al.
Cancer
|
June 15, 1981
Management of breast cancer patients failing adjuvant chemotherapy with adriamycin-containing regimens
A U Buzdar, S S Legha, G N Hortobagyi, et al.
Cancer Treatment Reports
|
February 1, 1982
High-dose AMSA and bone marrow rescue in patients with solid tumors
A R Zander, G Spitzer, S Legha, et al.
Page
of 18
Search research articles
Search
Showing results (161-170 of 179) with videos related to
Sort By:
Page
of 18
Annals of Internal Medicine
|
December 1, 1979
Complete remissions in metastatic breast cancer treated with combination drug therapy
S S Legha, A U Buzdar, T L Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1987
Evaluation of high-dose versus standard FAC chemotherapy for advanced breast cancer in protected environment units: a prospective randomized study
G N Hortobagyi, G P Bodey, A U Buzdar, et al.
Cancer Treatment Reports
|
January 1, 1980
Chemoimmunotherapy for metastatic breast cancer with 5-fluorouracil, adriamycin, cyclophosphamide, methotrexate, L-asparaginase, Corynebacterium parvum, and Pseudomonas vaccine
G N Hortobagyi, H Y Yap, C L Wiseman, et al.
In Vivo (Athens, Greece)
|
November 1, 1991
Immunological properties of melanoma tumor-infiltrating lymphocytes before and after IL-2-based biotherapies
K Itoh, C M Balch, J L Murray, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 14, 2006
Multicenter phase III randomized trial of polychemotherapy (CVD regimen) versus the same chemotherapy (CT) plus subcutaneous interleukin-2 and interferon-alpha2b in metastatic melanoma
E Bajetta, M Del Vecchio, P Nova, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1995
Phase II trial of docetaxel in patients with advanced cutaneous malignant melanoma previously untreated with chemotherapy
A Y Bedikian, G R Weiss, S S Legha, et al.
Melanoma Research
|
June 4, 1998
DNA damage in peripheral blood mononuclear cells correlates with response to biochemotherapy in melanoma
A C Buzaid, F Ali-Osman, N Akande, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy
|
October 1, 1991
Study of tumor-infiltrating lymphocytes for adoptive therapy of renal cell carcinoma (RCC) and metastatic melanoma: sequential proliferation of cytotoxic natural killer and noncytotoxic T cells in RCC
K Hayakawa, M A Salmeron, D R Parkinson, et al.
Cancer
|
June 15, 1981
Management of breast cancer patients failing adjuvant chemotherapy with adriamycin-containing regimens
A U Buzdar, S S Legha, G N Hortobagyi, et al.
Cancer Treatment Reports
|
February 1, 1982
High-dose AMSA and bone marrow rescue in patients with solid tumors
A R Zander, G Spitzer, S Legha, et al.
Page
of 18